Cloned DNA sequence related to genomic RNA of human immunodeficiency virus (HIV-1)

US7217508B1 · kind B1 · utility

Assignees

• INSTITUT PASTEUR · FR
• The United States of America, as represented by the Department of Health and Human Services · US

Inventors

• Jacqueline Gruest · L'Haÿ-les-Roses, FR
• Solange Chamaret · Paris, FR
• Claudine Axler-Blin · Paris, FR
• Francoise Rey · Paris, FR
• Marie-Therese Nugeyre · Paris, FR
• Charles Dauguet · Paris, FR
• Willy Rozenbaum · Paris, FR
• Christine Rouzioux · Paris, FR
• Francois Brun-Vezinet · Paris, FR
• Luc Montagnier · Le Plessis-Robinson, FR
• Jean-Claude Chermann · Marseilles, FR
• Francoise Barre-Sinoussi · Issy-les-Moulineaux, FR
• Pierre Tiollais · Paris, FR
• Marc Alizon · Paris, FR
• Pierre Sonigo · Paris, FR
• Stewart Cole · Clamart, FR
• Oliver Danos · Fontainebleau, FR
• Robert C. Gallo · Bethesda, US
• Mikulas Popovic · Bethesda, US
• Mangalasseril G. Sarngadharan · Vienna, US
• Simon Wain-Hobson · Montigny-le-Bretonneux, FR

Key dates

• Filing date: Feb 22, 1988
• Grant date: May 15, 2007
• Expiry date: Feb 22, 2008

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12Q1/703
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

This invention is in the field of lymphadenopathy virus, which has been designated Human Immunodeficiency Virus Type 1 (HIV-1). This invention relates to a diagnostic means and method to detect the presence of DNA, RNA or antibodies of the lymphadenopathy retrovirus associated with the acquired immune deficiency syndrome or of the lymphadenopathy syndrome by the use of DNA fragments or the peptides encoded by said DNA fragments. The invention further relates to the DNA fragments, vectors comprising them and the proteins expressed.